Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science

AMSTERDAM, August 30, 2010 -

    - Integrates ScienceDirect, Scopus and Targeted Web Content;
      Offers New Search and Discovery Applications -



    - Opening APIs to Encourage Development of Customized Solutions -

Elsevier, (www.elsevier.com/) a world-leading publisher of
scientific, technical and medical information products and services, today
announced the launch of SciVerse (www.sciverse.com/), an innovative
platform that integrates the company's key products and encourages the
scientific community to collaborate on the development of customized search
and discovery applications. Elsevier has committed to releasing the APIs
(application programming interfaces) for all of the content on SciVerse and
will offer application development support tools on the site.

"SciVerse is a start of a new journey for Elsevier where we plan to
provide customized search and discovery solutions and increase
interoperability within our products and third party services," said Jay
Katzen, Managing Director, Academic & Government Products, Elsevier. "We
recognize that it is critical to involve the researchers and librarians in
the creation of solutions as they are in the best position to identify and
address their search and discovery challenges. By providing our content APIs
later this year, we will empower researchers and developers to build custom
applications to enhance their workflow and share these applications with the
scientific community within SciVerse."

A multi-phased initiative aimed at accelerating science through
applications targeted to specific researcher needs, at launch SciVerse will
include SciVerse Hub beta, a module that integrates ScienceDirect
(www.sciencedirect.com/), Scopus (www.scopus.com/) and targeted
web content from Scirus, Elsevier's science-specific Internet search engine.
SciVerse Hub beta allows for a single search across its integrated content
with results ranked by relevancy and without duplication, saving valuable
researcher time.

Combining familiar resources with new efficiencies, SciVerse also enables
interoperability among ScienceDirect, Scopus and the new SciVerse Hub beta.
For example, ScienceDirect users who also subscribe to Scopus will now be
able to access key author information without leaving the article, and link
directly into comprehensive lists of all an author's documents and citations
in Scopus.

SciVerse Hub beta will include three search and discovery applications at
launch:

    - Methods section search application - allows researchers to search only
      the methodology and protocol sections of full-text articles.

    - Matching Sentences application - returns search results with the query
      words highlighted in the full sentence where they appear.

    - Prolific Authors application - prominently displays the most prolific
      authors for each search result.

The initial applications offer an example of the possible solutions that
can be built using content APIs and were developed by NextBio, a provider of
a SaaS (Software as a Service) platform for life sciences researchers which
includes ontology-based semantic tools. Elsevier began collaborating with
NextBio in 2009.

Elsevier will begin rolling out its APIs on SciVerse in Q4 of this year
including content APIs for ScienceDirect, Scopus, and SciVerse Hub beta. In
opening up this trusted content to development by the worldwide scientific
and developer communities, SciVerse will allow for collaboration on
applications that meet specific researcher challenges and enable the creation
of customized solutions for efficiently finding, using and re-using SciVerse
content.

"As a physician scientist, there is vast amount of information that is
available for potential discoveries which has limited my ability to find and
consume the right information in the time I have available for research,"
said Dr. Fatima Cody Stanford, Palmetto Health/ University of South Carolina
School of Medicine. "Applications that provide more intelligent results will
significantly improve my workflow. I am very excited about the first SciVerse
applications and eager to see new additions as the larger community begins
development."

For more information about SciVerse, please visit
www.info.sciverse.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell (
www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com/), Scopus (www.scopus.com/
), Reaxys (https://www.reaxys.com/), MD Consult (www.mdconsult.com/)
and Nursing Consult (www.nursingconsult.com/), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com/) and MEDai's Pinpoint Review (www.medai.com/),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com/), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Sandra Plasse/Jennifer Saunders
    +1-212-752-8338
    splasse@psbpr.com
    jsaunders@psbpr.com

Media Contact: Sandra Plasse/Jennifer Saunders, +1-212-752-8338, splasse at psbpr.com , jsaunders at psbpr.com .